Our business is split into three core areas. Generic Drug Substances (GDS) is still the heartland for many of our customers. Custom Manufacturing Solutions (CMS) is now nearly as large and is the fastest growing part of our business. Peptides is an expression of our expertise in a certain aspect of chemistry.
Neuland is at the forefront of facilitating and accelerating drug development and cGMP manufacturing of APIs. The Company’s technical and scientific teams provide reliable solutions and services to the global pharmaceutical industry.
Neuland follows a strong set of ethical values, termed ‘The Neuland Way’, that spurs integrity and motivation among the work force. The Neuland Way is made up of five defined values: Customer Centricity; Reliability; Accountability; Ownership; Openness & Transparency; and the core of Neuland’s business is built upon these values.
Neuland launches a new e-book. The collection of articles in this e-book discusses some of the key factors driving the pharmaceutical API industry.
Neuland will attend DCAT Week from March 23-26, 2020 in New York City. Meet us at Intercontinental Barclay at Room 401 & 402.
The Dizzying Confusion of Drug Pricing Regulations
Posted on April 4, 2021 by Saharsh Davuluri
In 2019, drug pricing was expected to be a top drug industry issue heading into the New Year. Things changed in 2020. The pharma industry (and the whole world) was…well…slightly…
Neuland is committed to its stakeholders for their sustainable and long-term enrichment. Investor Relations is a top priority and we aim to meet all expectations with timely and reliable information.
Neuland facilitates accelerated career growth for self-driven and motivated professionals who are willing to learn, explore and flourish with the company. If you would like to make a career with us in R&D, manufacturing, engineering, sales and marketing, finance, or supply chain management then we’d like to hear from you.